Skip to contentC
cbdMD, Inc.
C
YCBDcbdMD, Inc. Q3 2025 · 10-Q
Revenue$4.61M$4.61M−11.0% vs Q3 2024 Net Income-$895.27K-$895.27KN/M vs Q3 2024 EPS, diluted—
Gross Profit$2,831,087−16.8% Operating Income-$904,686N/M The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
cbdMD, Inc. · CIK 1644903 · Engraved from SEC EDGAR
Operating Cash Flowderived-$704,200N/M Free Cash Flowderived-$705,675N/M Margins · derivedGross margin61.5%−4.3 pt vs Q3 2024
Operating margin-19.6%−12.3 pt vs Q3 2024
Net margin-19.4%−28.3 pt vs Q3 2024
ended Jun 30, 2025 · filed Aug 14, 2025 · 45 d after period end